Business Wire Feed
Lantern Pharma Inc. Announces up to $9.25 Million Registered Direct Offering with Existing Holders and a Single Institutional Investor
$4.4 million upfront with up to an additional $4.85 million of potential aggregate gross proceeds upon the exercise in full of the warrants Offering priced at the closing price with unregistered warrants exercisable at a more...
Seven Northwell Hospitals Earn CMS 5-star Ratings
Danbury, Glen Cove, Huntington, Lenox Hill, Mather, North Shore University, Northern Westchester and Sharon hospitals get top marks from government agencyNEW HYDE PARK, N.Y.--(BUSINESS WIRE)--Twelve Northwell Health hospitals have received four-star or better ratings from more...
Videa Launches Ambient Intelligence, Extending Voice AI from Documentation to Practice Insights
New category of conversational intelligence builds on Videa’s integrated AI platform and advances leadership in voice AI for dentistryBOSTON--(BUSINESS WIRE)--Videa, the most adopted dental AI platform, today announced Ambient Intelligence, a new category of conversational more...
Cleveland Diagnostics Achieves ISO 13485:2016 Certification, Advancing Commercial Expansion for IsoPSA® IVD Assay
Regulatory milestone positions Cleveland Diagnostics for faster transition from FDA approval to commercial expansion of its novel prostate cancer testCLEVELAND--(BUSINESS WIRE)--Cleveland Diagnostics, Inc., a commercial-stage precision oncology company, recently received ISO 13485:2016 certification, the globally more...
FORE Biotherapeutics to Participate in Upcoming Investor Conferences
PHILADELPHIA--(BUSINESS WIRE)--FORE Biotherapeutics today announced that the Company will participate at the following investor conferences: Stifel 2026 Virtual Targeted Oncology Forum. The Company will attend on Tuesday, May 19, and will participate in a fireside more...
Delcath Systems to Participate at the H.C. Wainwright 4th Annual BioConnect Investor Conference
QUEENSBURY, N.Y.--(BUSINESS WIRE)--Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, today announced that management will be attending the H.C. Wainwright 4th Annual more...
ConcertAI Appoints Shawn W. Bates as General Manager, Commercial Solutions
Veteran life sciences and AI commercial leader joins ConcertAI to lead growth and transform delivery across Commercial SolutionsCAMBRIDGE, Mass.--(BUSINESS WIRE)--ConcertAI®, the real‑world healthcare intelligence company for those advancing research, treatment, and care in oncology and more...
Real-World PEDD Study Published in the Journal of Comparative Effectiveness Research Shows Improved Clinical Outcomes and Meaningful Charge Avoidance
Study of 603 PEDD patients and 16,210 non-PEDD patients found PEDD technology was associated with fewer post-procedure complications, reduced hospitalizations, and approximately $7,700 in per-patient charge avoidance despite greater baseline clinical complexityWESTMINSTER, Colo.--(BUSINESS WIRE)--TriSalus Life more...
Vyome Strikes Deal With Impetis Biosciences, Opening A ~$57B Market Opportunity
Vyome has signed an agreement with Impetis, a TATA Enterprise, to in-license two selective JAK inhibitor assets, opening access to a large and growing ~$57B global market¹ These next-generation JAK inhibitors are designed for higher more...
NeuroVision Acquires Durin Life Sciences to Advance Earlier Detection and Management of Neurodegenerative Disease
Combined company brings together blood-based diagnostics, retinal imaging, and a national patient-facing telehealth platform to support earlier intervention and longitudinal careSACRAMENTO, Calif.--(BUSINESS WIRE)--NeuroVision Imaging Inc. today announced the acquisition of Durin Life Sciences Inc., creating more...
Medbridge Debuts First Rehabilitation and Physical Therapy Care Intelligence Loop
Addition of Medbridge Outcomes to the Medbridge One Care platform delivers the ability to continuously improve clinician skill, care delivery, and patient outcomes in a single systemBELLEVUE, Wash.--(BUSINESS WIRE)--Medbridge, a leader in digital care solutions more...
Response Pharmaceuticals to Present Data on RDX-002 in Antipsychotic-Induced Weight Gain at the 2026 American Psychiatric Association Annual Meeting
Poster presentation will highlight Phase 1b data on RDX-002, an investigational, first-in-class, gut-restricted inhibitor of intestinal MTP in development for atypical antipsychotic-induced weight gain, a leading driver of treatment discontinuation among patients on atypical antipsychoticsFALLS more...
The Vitamin Shoppe to Add Shakeology by BODi in Retail Locations Nationwide
EL SEGUNDO, Calif.--(BUSINESS WIRE)--BODi (NASDAQ: BODI), the proactive wellness company delivering nutrition, supplements, and proven fitness programs that help people take control of their health inside and out, today announced that its premium protein and more...
Health Info Net Advances Sovereign Digital Healthcare With Red Hat and VSHN
HIN accelerates operational efficiency and scales digital healthcare services with a resilient foundation powered by Red Hat OpenShiftATLANTA – RED HAT SUMMIT--(BUSINESS WIRE)--Red Hat, the world’s leading provider of open source solutions, today announced its more...
HistoSonics Moves to Advance Additional Histotripsy Applications Announcing FDA Submission for Kidney Tumors
MINNEAPOLIS--(BUSINESS WIRE)--#HistoSonics--HistoSonics, the developer of the Edison® Histotripsy System and novel histotripsy therapy platform, today announced it has submitted a De Novo request to the U.S. Food and Drug Administration seeking authorization to expand the more...
Media Advisory: Surescripts to Highlight Smarter Health Intelligence Sharing That Helps Close Gaps in Patient Care at AHIP 2026
ARLINGTON, Va.--(BUSINESS WIRE)--#HealthIT--Surescripts®, the nation’s leading health intelligence network, will present at AHIP 2026, taking place June 9–10, in Las Vegas, Nevada. Surescripts’ interoperability experts Justin McMartin and Matt Hartzler will present: From Communication to more...
CEL-SCI Enters Strategic Agreement with Amarox for the Registration, Commercialization, and Distribution of Multikine in Saudi Arabia
50%/50% revenue sharing agreement for Multikine sales in Saudi Arabia upon receipt of Breakthrough Medicine Designation Amarox to act as the local regulatory representative and lead all communications with the Saudi Food and Drug Authority more...
Avenacy Announces Launch of Ready-to-Use Tranexamic Acid in 0.7% Sodium Chloride Injection in the U.S. Market
Represents the Company’s 27th product launch since inception in October 2023SCHAUMBURG, Ill.--(BUSINESS WIRE)--Avenacy, a specialty pharmaceutical company focused on supplying critical injectable medications, today announced it has launched Tranexamic Acid in 0.7% Sodium Chloride Injection more...
Claritev Corporation Announces Participation in BofA Securities Global Health Care Conference 2026
MCLEAN, Va.--(BUSINESS WIRE)--Claritev Corporation (“Claritev” or the “Company”) (NYSE: CTEV), a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, today announced that members of its management team more...
Iambic to Participate in Upcoming Investor Conferences
SAN DIEGO--(BUSINESS WIRE)--Iambic, a clinical-stage life science and technology company developing novel medicines using its AI-driven platform, today announced its participation in upcoming investor conferences: Bank of America Healthcare Conference: May 12-14 Jefferies Global Healthcare more...
OM1 Supports 650,000 Patient Real-World Regulatory Submission for FDA Approval of Hologic’s Aptima HPV Assay
Massive study demonstrates how AI-enabled evidence generation can meet the FDA's bar for decision-makingBOSTON--(BUSINESS WIRE)--OM1, a real-world evidence generation company and the leading AI outcomes platform, presented its role in the landmark study that supported more...
Therorna to Showcase Clinical-Ready Circular RNA in vivo CAR-T and CircRNA Pipeline at the 2026 American Society of Gene & Cell Therapy (ASGCT) Annual Meeting
TI-0032 first-in-human study initiated; US/China dual IND filing on trackBEIJING & SHANGHAI--(BUSINESS WIRE)--#ASGCT2026--Therorna Inc., a clinical-stage biotechnology company pioneering circular RNA (circRNA)-based therapies, today announced that the company will present three posters at the 2026 more...
Coolibar and Skin Cancer Survivor and Advocate, Dayanara Torres, Redefine Life in the Sun for Skin Cancer Awareness Month
MIAMI--(BUSINESS WIRE)--#Coolibar--Coolibar, the world’s leading UPF 50+ sun protection apparel brand, is continuing its partnership with skin cancer survivor and advocate Dayanara Torres and the Melanoma Research Foundation (MRF) for Skin Cancer Awareness Month this more...
Saban Community Clinic Breaks Ground on Crenshaw Family Health Center, Expanding Access For Over 287,000 Low-Income People in One of Los Angeles’ Most Underserved Communities
New Facility Will Bring Integrated Care to South Los Angeles, Where Families Lack Reliable Access to Primary CareLOS ANGELES--(BUSINESS WIRE)--#Clinic--Saban Community Clinic (SCC) today breaks ground on its new Crenshaw Family Health Center, a major more...
Sensus Healthcare Announces Amicable Resolution of Commercial Dispute with SkinCure Oncology
BOCA RATON, Fla.--(BUSINESS WIRE)--Sensus Healthcare, a medical device company committed to providing highly effective, non-invasive treatments for oncological and non-oncological skin conditions, today announced that SkinCure Oncology and Sensus Healthcare have amicably resolved their dispute more...